Business Wire

Armis Launches Armis Centrix™, the AI-powered Cyber Exposure Management Platform

13.9.2023 15:00:00 EEST | Business Wire | Press release

Share

Armis, the asset intelligence cybersecurity company, today announced the launch of Armis Centrix™, the AI-powered cyber exposure management platform. Armis Centrix™ is a seamless, frictionless, cloud-based platform that proactively secures all your assets, remediates vulnerabilities, blocks threats and protects your entire attack surface.

Armis Centrix™ enables organizations to discover, contextualize, enrich and profile every asset in their environment whilst also building a line of defense by leveraging Armis Centrix™ Asset Intelligence risk scores, policies, alerting and visualizations and most importantly: prioritize efforts against the exposures that matter to your business. Armis Centrix™ also integrates with existing enforcement and ticketing tools to establish end-to-end workflows and true risk lifecycle management and track risk reduction efforts to easily report on progress made. Armis Centrix™ takes proactive measures, detects threats & stops attacks to establish operational workflows and track risk reduction.

“In a perimeter-less world, where assets are digitally connected, traditional cybersecurity boundaries no longer exist. Legacy on-premise systems and point solutions are no longer fit for purpose leaving your attack surface and most critical assets open and exposed to cyber criminals and multiple bad actors,” said Nadir Izrael, CTO and Co-Founder, Armis. “The sheer scale and dynamic nature of the attack surface necessitates an entirely different, AI-driven approach, and that’s what Armis Centrix™ is - the AI that powers a suite of powerful tools for managing cyber risk exposure.”

Armis Centrix™ helps organizations see, protect and manage their entire attack surface, continuously safeguarding their mission-critical assets from cyber threats. Born in the cloud and fueled by AI, only Armis Centrix™ delivers a true modular approach to cyber exposure management covering the most critical cybersecurity needs for our clients across 4 solutions:

  • Asset management and security - Complete asset inventory of all asset types allowing any organization to see and secure the attack surface
  • OT/IOT security - See and secure OT/IOT networks and physical assets, ensure uptime and build an effective & comprehensive security strategy
  • Medical device security - Complete visibility and security for all medical devices, clinical assets and the entire healthcare ecosystem - with zero disruption to patient care
  • Vulnerability prioritization and remediation - Consolidate, prioritize and remediate all vulnerabilities; improve mean time to remediation (MTTR) with automatic remediation and ticketing workflows

“This is a revolutionary advancement that will change the way in which companies answer key questions regarding their cybersecurity posture,” said Dana Gilboa, Chief Product Officer, Armis. “Armis can help organizations mitigate their cyber asset risks and protect the entire attack surface by providing the needed intelligence to align security and business efforts. With this approach, we can ultimately provide organizations with the peace of mind they need, allowing them to see, protect and manage all their critical assets.”

Armis Centrix™ is industry-agnostic, allowing Manufacturing, Health and Medical, Information Technology, Energy and Utilities, Financial Services, Transportation, Telecommunications and Media, Public Sector and many more to benefit from its capabilities. Additionally, Armis collaborates with the world’s premier global technology vendors to ensure its customers can seamlessly integrate the Armis Centrix™ platform with existing IT and security stacks.

If you would like to know more about Armis Centrix™, the cyber exposure management platform, visit armis.com/centrix or contact us at info@armis.com.

About Armis

Armis, the asset intelligence cybersecurity company, protects the entire attack surface and manages the organization's cyber risk exposure in real time. In a rapidly evolving, perimeter-less world Armis ensures that organizations continuously see, secure, protect and manage all critical assets. Armis secures Fortune 100, 200 and 500 companies as well as national governments, state and local entities to help keep critical infrastructure, economies and society safe and secure 24/7. Armis is a privately held company headquartered in California.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Rebecca Cradick
Senior Director, Global Communications
Armis
pr@armis.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 18:08:00 EEST | Press release

HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye